Product Information

ESCITALOPRAM 5 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0441 per EA under NDC 60687086501. Its NADAC has been published 84 times since Apr 16, 2025.

FDA first approved this application on Aug 28, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ESCITALOPRAM 5 MG TABLET

Escitalopram
$0.0441per EA

Strength

5 mg/1

NDC

60687086501

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ESCITALOPRAM OXALATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078032

FDA Approved

8/28/2015

TE Code

AB

On Market Since

3/20/2025

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for ESCITALOPRAM 5 MG TABLET has been published 84 times since Apr 16, 2025, and over the history we have for it it has declined 3.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0441 per EA
All-time high$0.0474 (Jul 16, 2025)
All-time low$0.0412 (Mar 18, 2026)
52-week high$0.0441
52-week low$0.0412
Median price$0.0423
Average price$0.0433
Largest weekly change-6.9% (Sep 17, 2025)
Weeks tracked84
Tracking sinceApr 16, 2025

Price History

1W

+2.8%

1M

+6.0%

3M

+5.1%

6M

+5.2%

1Y

+6.9%

3Y

N/A

5Y

N/A

All

-3.1%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ESCITALOPRAM 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by American Health Packaging, is $0.0441 per EA (NDC 60687086501), effective Nov 18, 2026.

How has the price of ESCITALOPRAM 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has declined 3.1%. It has been tracked across 84 weekly CMS publications since Apr 16, 2025.

What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?

Since Apr 16, 2025, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0412 (Mar 18, 2026) to a high of $0.0474 (Jul 16, 2025), with a median of $0.0423 per EA.

Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESCITALOPRAM 5 MG TABLET, is $0.0419 per EA — about 5% below ESCITALOPRAM 5 MG TABLET.

Who manufactures ESCITALOPRAM 5 MG TABLET?

ESCITALOPRAM 5 MG TABLET (NDC 60687086501) is labeled by American Health Packaging, and CMS classifies it as a generic product.